India’s economy has seen a remarkable surge in recent years, growing from USD 10 billion in 2014 to over USD 130 billion in 2024, with projections aiming at reaching an impressive USD 300 billion by 2030. This incredible growth reflects the country’s transformation into a global biotech powerhouse, with Prime Minister Narendra Modi being hailed as a champion of the new Biotech Boom. The recent release of the groundbreaking BioE3 policy aims to further enhance the bioeconomy and propel India towards a vision of ‘Viksit Bharat @2047’.
Dr Jitendra Singh, Union Minister of State for Science and Technology, praised this extraordinary growth while launching the BioE3 policy at the Media Centre. The policy is designed to foster high-performance biomanufacturing and align with national initiatives such as the ‘Net Zero’ carbon economy and Mission LiFE (Lifestyle for Environment). It is expected to have a significant impact on various sectors including food, energy, and health. Dr. Singh highlighted the importance of the Public-Private Partnership (PPP) model in implementing the policy, encouraging industry participation and promoting employment generation.
The BioE3 policy focuses on six thematic areas: bio-based chemicals and enzymes, functional foods and smart proteins, precision biotherapeutics, climate-resilient agriculture, carbon capture and utilisation, and futuristic marine and space research. Dr. Singh emphasized that the policy’s emphasis on bio-manufacturing and bio-foundries will drive India’s future bioeconomy and promote “Green Growth”. He highlighted India’s vast wealth of bioresources, biodiversity, and unique advantages in biotechnology, such as the country’s long coastline and the recent launch of the Deep Sea Mission.
Dr. Singh also recalled the exponential growth of India’s bio economy over the past decade, from USD 10 billion in 2014 to over USD 130 billion in 2024, and projected to reach USD 300 billion by 2030. He reiterated the enormous potential of biotechnology in driving the next revolution of the 21st Generation, stating that while the IT revolution was West-driven, the Biotechnology revolution will be India-driven. The release of the BioE3 policy marks a significant milestone in India’s bioeconomy and sets the stage for further growth and innovation in the sector.
Other key figures present at the release of the policy included Dr. Rajesh Gokhale, Secretary Department of Bio-Technology, and Dr. VK Saraswat, Member of Niti Ayog. Their presence underscored the importance of the BioE3 policy in driving India’s bioeconomy forward and establishing the country as a global leader in biotechnology. Overall, the policy is set to revolutionize various sectors and play a pivotal role in shaping the future of India’s bioeconomy towards sustainable growth and development.
